| 08.05 08:26 | dpa-AFX: *SMITH & NEPHEW ANNOUNCES DIRECTORATE CHANGES |
| 03.05 05:19 | dpa-AFX: *JEFFERIES CUTS SMITH & NEPHEW PRICE TARGET TO 1250 (1300) PENCE - 'BUY' |
| 02.05 07:29 | dpa-AFX: *BARCLAYS CUTS SMITH & NEPHEW PRICE TARGET TO 1190 (1200) PENCE - 'EQUAL WEIGHT' |
| 02.05 05:47 | dpa-AFX: *JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1381 (1300) PENCE - 'OVERWEIGHT' |
| 01.05 09:15 | dpa-AFX: *SMITH & NEPHEW +2,0% NACH ZAHLEN ZUM ERSTEN QUARTAL |
| 01.05 08:23 | dpa-AFX: Smith+Nephew Q1 Revenue Up 2.9% On Underlying Basis |
| 01.05 08:06 | dpa-AFX: *SMITH+NEPHEW Q1 REVENUE $1.386 BLN, UP 2.9% ON UNDERLYING BASIS |
| 01.05 08:04 | dpa-AFX: *SMITH & NEPHEW CONTINUE TO EXPECT FY24 UNDERLYING REVENUE GROWTH OF 5.0% TO 6.0% |
| 01.05 08:04 | dpa-AFX: *SMITH & NEPHEW Q1 REVENUE UP 2.9% TO $1.386 ON UNDERLYING BASIS |
| 18.04 13:00 | dpa-AFX: GNW-Adhoc: Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention |
| 04.04 17:13 | dpa-AFX: GNW-Adhoc: Smith+Nephew's PICOT Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE) |
| 28.03 08:24 | dpa-AFX: Smith+Nephew : John Rogers To Join Board As Executive Director And CFO On 1 April |
| 28.03 08:04 | dpa-AFX: *SMITH+NEPHEW SAYS JOHN ROGERS WILL JOIN THE BOARD AS EXECUTIVE DIRECTOR AND CFO ON APRIL 1 |
| 25.03 13:00 | dpa-AFX: GNW-Adhoc: Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner |
| 14.03 08:16 | dpa-AFX: *SMITH & NEPHEW COMPLETES PRICING OF $350 MLN 5.150% NOTES DUE 2027 AND $650 MLN 5.400% NOTES DUE 2034 |
| 04.03 05:18 | dpa-AFX: *JEFFERIES RAISES SMITH & NEPHEW PRICE TARGET TO 1300 (1250) PENCE - 'BUY' |
| 28.02 07:07 | dpa-AFX: *BARCLAYS RAISES SMITH & NEPHEW PRICE TARGET TO 1200 (1150) P - 'EQUAL WEIGHT' |
| 27.02 09:18 | dpa-AFX: *SMITH & NEPHEW +1,7% - ZAHLEN ÜBER ERWARTUNGEN - JEFFERIES |
| 27.02 08:43 | dpa-AFX: Smith & Nephew FY Trading Profit Rises; Revenue Up 7.2% On Underlying Basis |
| 27.02 08:08 | dpa-AFX: *SMITH & NEPHEW EXPECTS FY24 UNDERLYING REVENUE GROWTH OF 5.0% TO 6.0% |
|
|
